BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 11101847)

  • 21. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
    Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of telomerase activity by the p53 family member p73.
    Beitzinger M; Oswald C; Beinoraviciute-Kellner R; Stiewe T
    Oncogene; 2006 Feb; 25(6):813-26. PubMed ID: 16205639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.
    Pierce AM; Gimenez-Conti IB; Schneider-Broussard R; Martinez LA; Conti CJ; Johnson DG
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8858-63. PubMed ID: 9671769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the transcription factor DP in apoptosis.
    Hitchens MR; Robbins PD
    Apoptosis; 2003 Oct; 8(5):461-8. PubMed ID: 12975577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of p63 and p73 expression.
    Waltermann A; Kartasheva NN; Dobbelstein M
    Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity.
    Tomasini R; Seux M; Nowak J; Bontemps C; Carrier A; Dagorn JC; Pébusque MJ; Iovanna JL; Dusetti NJ
    Oncogene; 2005 Dec; 24(55):8093-104. PubMed ID: 16044147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the interleukin 4 receptor alpha gene as a direct target for p73.
    Sasaki Y; Mita H; Toyota M; Ishida S; Morimoto I; Yamashita T; Tanaka T; Imai K; Nakamura Y; Tokino T
    Cancer Res; 2003 Dec; 63(23):8145-52. PubMed ID: 14678968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The C terminus of p53 family proteins is a cell fate determinant.
    Harms KL; Chen X
    Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors.
    Pan H; Yin C; Dyson NJ; Harlow E; Yamasaki L; Van Dyke T
    Mol Cell; 1998 Sep; 2(3):283-92. PubMed ID: 9774967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.
    Urist M; Tanaka T; Poyurovsky MV; Prives C
    Genes Dev; 2004 Dec; 18(24):3041-54. PubMed ID: 15601819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of p73beta by a naphthoquinone analog is mediated by E2F-1 and triggers apoptosis in HeLa cells.
    Kang KH; Lee JH; Kim KC; Ham SW; Kim MY; Choi KH
    FEBS Lett; 2002 Jul; 522(1-3):161-7. PubMed ID: 12095638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2.
    Kowalik TF; DeGregori J; Leone G; Jakoi L; Nevins JR
    Cell Growth Differ; 1998 Feb; 9(2):113-8. PubMed ID: 9486847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis.
    Yang SZ; Lin FT; Lin WC
    EMBO Rep; 2008 Sep; 9(9):907-15. PubMed ID: 18660752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p73 transcriptional activity increases upon cooperation between its spliced forms.
    Alarcon-Vargas D; Fuchs SY; Deb S; Ronai Z
    Oncogene; 2000 Feb; 19(6):831-5. PubMed ID: 10698502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 induction.
    Rödicker F; Stiewe T; Zimmermann S; Pützer BM
    Cancer Res; 2001 Oct; 61(19):7052-5. PubMed ID: 11585734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wild-type p53 and p73 negatively regulate expression of proliferation related genes.
    Scian MJ; Carchman EH; Mohanraj L; Stagliano KE; Anderson MA; Deb D; Crane BM; Kiyono T; Windle B; Deb SP; Deb S
    Oncogene; 2008 Apr; 27(18):2583-93. PubMed ID: 17982488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family.
    Attardi LD; Reczek EE; Cosmas C; Demicco EG; McCurrach ME; Lowe SW; Jacks T
    Genes Dev; 2000 Mar; 14(6):704-18. PubMed ID: 10733530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation.
    Melino G; Bernassola F; Ranalli M; Yee K; Zong WX; Corazzari M; Knight RA; Green DR; Thompson C; Vousden KH
    J Biol Chem; 2004 Feb; 279(9):8076-83. PubMed ID: 14634023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria.
    John K; Alla V; Meier C; Pützer BM
    Cell Death Differ; 2011 May; 18(5):874-86. PubMed ID: 21127500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of p73 in malignancy: tumor suppressor or oncogene?
    Stiewe T; Pützer BM
    Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.